Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients

NCT05147090 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis b
NAFLD
Cirrhosis
Fibrosis, Liver
Empagliflozin
SGLT2 Inhibitors

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Placebo pills

Sponsor

The University of Hong Kong

Collaborators

[object Object]